This study investigates whether an experimental medication is effective in slowing the progression of preclinical Alzheimer’s Disease in individuals with mild symptoms with or without a family history of AD.
Local Recruitment Point of Contact
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu
Local Recruitment Point of Contact
Haritha Vardhini Katragadda
(210) 450-8437
katragaddah@uthscsa.edu
Overall Recruitment Point of Contact
Arash Salardini
(210) 450-8437
salardini@uthscsa.edu
Principal Investigator
Arash Salardini
Regulatory Point of Contact
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu
Regulatory Point of Contact
Haritha Vardhini Katragadda
(210) 450-8437
katragaddah@uthscsa.edu
Participants must have a study partner who is willing to provide information about the individual’s daily activities. ???????
Recent history of stroke, seizures, or major psychiatric illness. Inability to complete MRI scans.